Brighter and Chronos Care Enter into Proof of Concept Collaboration for Actiste

Report this content

Brighter AB (publ), announced today that the company has entered into a collaboration agreement with Chronos Care (Chronos Labs AB) to conduct a “Proof of Concept” to verify Brighter’s Actiste service and evaluate the potential for future commercial collaboration in Sweden to provide accessible diabetes care to all, anytime, anywhere. During the proof of concept, Chronos Care will also provide Brighter with feedback on Actiste Diabetes Management as a Service (ADMS) from physicians and nurses who work with Chronos Care and its patients.

The scope of the collaboration includes using the ADMS for six (6) months to evaluate the benefits generated by the connected ADMS and its foreseen added value on patient adherence, quality of life, and the healthcare provider's possibility to interact with the patient based on input related to his or her real-life data. Ten (10) patients diagnosed with type 1 or type 2 diabetes will be selected to participate in the proof of concept. The patients will be given the opportunity to use ADMS (either with Actiste or Actiste Mini, depending on their circumstances) free of charge for six months, within the Brighter Ambassador Program.

“At Chronos Care, we are on a mission to change the lives of millions of people living with diabetes all around the world. We approach this by combining tech with healthcare. As we're joining the Ambassadors Programme at Brighter, we hope to combine the best from both parties to ultimately come closer to providing the absolute best and most scalable diabetes care worldwide” says Vidar Duvnäs co-founder and Business developer.

“This strategic collaboration will help Brighter hear the voices of both patients and health care providers in Sweden. Furthermore, it will be an important step towards our commercialization phase, since it comes during the launch phase of the Actiste Mini in the country, and Chronos patients will be the first to use Mini in Sweden,” says Christer Trägårdh, acting CEO at Brighter.

For more information, please contact:

Investor Relations

Certified Adviser

Brighter's Certified Adviser is Eminova Fondkommission AB, +46 [0)8 - 684 211 10,,

About Chronos Care:

Half a million Swedes live with diabetes, and a large part both need and want more support than they are able to get within primary healthcare. That's why Chronos Care has built a national team of experts who can help patients through video appointments with everything related to diabetes, including medication, diet, exercise, sleep and stress. Chronos Care combines tech with diabetes healthcare, where the focus lies in high continuity and a motivational way coaching patients towards lifestyle change. Chronos Care's ambition is to enable every patient to be able to live a good life without being hindered by their diabetes. Whether it is via video or chat, Chronos Care is always there for the patient to provide support in their everyday life and ultimately reduce the risk of long-term complications.

About Brighter AB (publ)

Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers – aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO-13485 certified. In 2019 the company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG.